BEHAVIORAL SENSITIZATION IN 6-HYDROXYDOPAMINE LESIONED RATS INVOLVES THE DOPAMINE SIGNAL-TRANSDUCTION - CHANGES IN DARPP-32 PHOSPHORYLATION

被引:36
作者
BARONE, P [1 ]
MORELLI, M [1 ]
POPOLI, M [1 ]
CICARELLI, G [1 ]
CAMPANELLA, G [1 ]
DICHIARA, G [1 ]
机构
[1] UNIV CAGLIARI,DEPT TOXICOL,CAGLIARI,ITALY
关键词
D O I
10.1016/0306-4522(94)90409-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
''Priming'' is a phenomenon of behavioural sensitization observed in unilaterally 6-hydroxy-dopamine lesioned rats following exposure to a dopamine agonist. After priming, a single dose of the D-1 agonist SKF 38393 (3 mg/kg) produces contralateral turning, while the same dose is inactive in drug-naive, lesioned animals. The molecular mechanisms of ''priming'' were investigated here by studying the phosphorylation of dopamine and adenosine 3'-5' monophosphate regulated phosphoprotein (DARPP-32), a dopamine- and cyclic AMP-regulated phosphoprotein functionally linked to D-1 receptors in striatum. Dephospho-form of DARPP-32 was measured by a back-phosphorylation assay. All assays were performed in striata from both lesioned and unlesioned sides. A significant decrease of dephospho-DARPP-32 (27%) was observed in the denervated striatum of primed rats, indicating an increased phosphorylation in vivo of DARPP-32 in response to the D-1 agonist. The levels of DARPP-32 protein. as measured by quantitative immunoblotting, remained unchanged in all experimental groups. This study shows that priming is expressed as an increased transduction of the D-1 receptor message.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 36 条
  • [1] [Anonymous], 1979, STEREOTAXIC ATLAS RA
  • [2] DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS
    BARONE, P
    BANKIEWICZ, KS
    CORSINI, GU
    KOPIN, IJ
    CHASE, TN
    [J]. NEUROLOGY, 1987, 37 (10) : 1592 - 1595
  • [3] BEITNERJOHNSON D, 1992, ANN NY ACAD SCI, V684, P71
  • [4] BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675
  • [5] SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE
    BRAUN, A
    FABBRINI, G
    MOURADIAN, MM
    SERRATI, C
    BARONE, P
    CHASE, TN
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) : 41 - 50
  • [6] DOPAMINE D-1 RECEPTOR AND CYCLIC AMP-DEPENDENT PHOSPHORYLATION IN PARKINSONS-DISEASE
    CASH, R
    RAISMAN, R
    PLOSKA, A
    AGID, Y
    [J]. JOURNAL OF NEUROCHEMISTRY, 1987, 49 (04) : 1075 - 1083
  • [7] INVIVO MODULATION OF STRIATAL PHOSPHOPROTEINS BY DOPAMINERGIC AGENTS
    DILUCA, M
    CIMINO, M
    ABBRACCHIO, MP
    CATTABENI, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (4-5): : 321 - 328
  • [9] STRIATAL PHOSPHOPROTEINS IN PARKINSON DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY
    GIRAULT, JA
    RAISMANVOZARI, R
    AGID, Y
    GREENGARD, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) : 2493 - 2497
  • [10] GUITART X, 1982, J NEUROCHEM, V59, P1164